Patents by Inventor Yaoming Liang

Yaoming Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF REDUCING ARTEFACT VARIANTS IN HIGH THROUGHPUT-SEQUENCING AND USES THEREOF
    Publication number: 20240221866
    Abstract: A method of reducing an artefact variant in high-throughput sequencing, which belongs to the technical field of bioinformatics is provided. The method includes the steps of: firstly building a population variant frequency database and integrating to obtain a population variant frequency at each variant site, along with total population, scoring each variant site using the formula designed by the inventors, and dividing a sequence into a predetermined window size after each variant to obtain a plurality of region sequences, then synthetically analyzing the scores of variant sites within each region sequence, and finally excluding the artefact variant sites based on identification. As a result, the method can achieve the detection of all types of artefact variants, and offers advantages such as high efficiency, automation, accuracy and comprehensive detection.
    Type: Application
    Filed: June 21, 2021
    Publication date: July 4, 2024
    Inventors: Yuhuan MENG, Guibin LI, Xiaoqiang HUANG, Xijie FAN, Yafei MU, Xiaping MIAO, Jiecheng YUAN, Yating CHENG, Shihui YU, Yaoming LIANG
  • Immunoassays using antibodies specific to carbamazepine
    Patent number: 8569000
    Abstract: The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: October 29, 2013
    Assignee: Guangzhou Kingmed Center for Clinical Laboratory
    Inventors: Liuming Yu, Yaoming Liang, Hongbo Li
  • Antibodies specific to carbamazepine
    Patent number: 8563713
    Abstract: The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: October 22, 2013
    Assignee: Guangzhou Kingmed Center for Clinical Laboratory
    Inventors: Liuming Yu, Yaoming Liang, Hongbo Li
  • ANTIBODIES SPECIFIC TO CARBAMAZEPINE
    Publication number: 20120244546
    Abstract: The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
    Type: Application
    Filed: March 22, 2011
    Publication date: September 27, 2012
    Applicant: Guangzhou Kingmed Center for Clinical Laboratory
    Inventors: Liuming YU, Yaoming Liang, Hongbo Li
  • IMMUNOASSAYS USING ANTIBODIES SPECIFIC TO CARBAMAZEPINE
    Publication number: 20120244557
    Abstract: The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
    Type: Application
    Filed: March 22, 2011
    Publication date: September 27, 2012
    Applicant: Guangzhou Kingmed Center for Clinical Laboratory
    Inventors: Liuming YU, Yaoming Liang, Hongbo Li